2019 tables: Institutions - life sciences - corporate

The 2019 tables are based on Nature Index data from 1 January 2018 to 31 December 2018.

Table criteria

# Institution Share 2017 Share 2018 Count 2018 Change in Adjusted Share 2017-2018*
1 AstraZeneca plc, United Kingdom (UK) 18.93 19.79 83 -2.8%
2 GlaxoSmithKline plc. (GSK), United Kingdom (UK) 9.94 11.51 68 7.7%
3 Oxford Nanopore Technologies Ltd., United Kingdom (UK) 1.30 3 N/A
4 Earlham Institute (EI), United Kingdom (UK) 1.88 1.09 15 -45.9%
5 IONTAS Ltd., United Kingdom (UK) 0.53 1 N/A
6 Pisces Conservation Ltd., United Kingdom (UK) 0.50 1 N/A
7 Cambridge Display Technology Ltd., United Kingdom (UK) 0.36 1 N/A
8 Global Phasing Ltd., United Kingdom (UK) 0.25 1 N/A
9 Seascape Consultants Ltd., United Kingdom (UK) 0.23 2 N/A
10 OMass Technologies Limited, United Kingdom (UK) 0.15 0.22 4 35.9%
11 OnCorps, Inc., United Kingdom (UK) 0.20 1 N/A
12 CN Bio Innovations Limited, United Kingdom (UK) 0.18 1 N/A
13 Genomics plc, United Kingdom (UK) 0.13 0.15 2 11.0%
14 Capita plc, United Kingdom (UK) 0.11 0.15 2 20.9%
15 PsiOxus Therapeutics Ltd., United Kingdom (UK) 0.14 1 N/A
15 Ecometrics Research and Consulting (EMRC), United Kingdom (UK) 0.14 1 N/A
15 Bering Limited, United Kingdom (UK) 0.14 1 N/A
16 Unilever, United Kingdom (UK) 0.66 0.13 3 -82.2%
17 GammaDelta Therapeutics Ltd., United Kingdom (UK) 0.13 1 N/A
17 Domainex, United Kingdom (UK) 0.13 1 N/A
17 BP plc, United Kingdom (UK) 0.24 0.13 1 -51.0%
18 Malvern Instruments Ltd., United Kingdom (UK) 0.12 2 N/A
19 Genomics England Ltd., United Kingdom (UK) 0.03 0.12 5 333.9%
20 Synairgen Research Ltd, United Kingdom (UK) 0.12 1 N/A
21 Demuris Limited, United Kingdom (UK) 0.10 1 N/A
22 Cambridge Epigenetix (CEGX), United Kingdom (UK) 0.08 1 N/A
22 TwinsUK Limited, United Kingdom (UK) 0.08 1 N/A
23 Exonate, United Kingdom (UK) 0.07 1 N/A
24 Twyman Research Management Ltd. (TRM), United Kingdom (UK) 0.07 1 N/A
25 Inspiralis Limited, United Kingdom (UK) 0.06 1 N/A
26 ADAS UK Ltd., United Kingdom (UK) 0.17 0.06 1 -69.0%
27 BioPharmaSpec Ltd., United Kingdom (UK) 0.05 1 N/A
27 The Aleph Lab Ltd., United Kingdom (UK) 0.05 1 N/A
28 Fios Genomics, United Kingdom (UK) 0.05 1 N/A
29 Synome Ltd., United Kingdom (UK) 0.10 0.05 1 -57.7%
29 Arix Bioscience, United Kingdom (UK) 0.05 1 N/A
29 Thomsons Online Benefits, United Kingdom (UK) 0.05 1 N/A
29 XenoGesis Ltd., United Kingdom (UK) 0.05 1 N/A
30 Adprotech Ltd., United Kingdom (UK) 0.04 1 N/A
31 Midatech Pharma plc, United Kingdom (UK) 0.04 1 N/A
32 Del Puerto Limited, United Kingdom (UK) 0.04 1 N/A
32 PharmiWeb Solutions, United Kingdom (UK) 0.04 1 N/A
33 Canterbury Archaeological Trust Ltd., United Kingdom (UK) 0.02 0.04 1 46.1%
34 Eagle Genomics Ltd., United Kingdom (UK) 0.03 1 N/A
34 Immunocore Limited, United Kingdom (UK) 0.03 1 N/A
35 OrganOx Limited, United Kingdom (UK) 0.03 1 N/A
36 GlaxoSmithKline Harlow, United Kingdom (UK) 0.03 1 N/A
37 York Osteoarchaeology Ltd., United Kingdom (UK) 0.03 1 N/A
38 BrainPatch Ltd, United Kingdom (UK) 0.02 1 N/A
39 Wessex Archaeology Ltd., United Kingdom (UK) 0.02 1 N/A
40 Bioxydyn Ltd., United Kingdom (UK) 0.02 1 N/A
41 OxFORD Asset Management, United Kingdom (UK) 0.02 1 N/A
42 Sygnature Discovery Limited, United Kingdom (UK) 0.02 1 N/A
43 Sterling Pharma Solutions Ltd., United Kingdom (UK) 0.02 1 N/A
44 Serco Group plc, United Kingdom (UK) 0.03 0.01 1 -53.5%
45 NextMove Software Ltd., United Kingdom (UK) 0.01 1 N/A
46 Rio Tinto plc, United Kingdom (UK) 0.01 1 N/A
47 Flamingo Land Ltd., United Kingdom (UK) 0.00 1 N/A

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.